Yangyang Feng

机构：University of Macau, Yan'an University, Ningxia Medical University, Zhuhai Institute of Advanced Technology, City University of Macau

发表论文 7 篇 · 总被引 25 次 · h-index 3

代表论文

• Artesunate ameliorates osteoarthritis cartilage damage by updating MTA1 expression and promoting the transcriptional activation of LXA4 to suppress the JAK2/STAT3 signaling pathway (2022 · Human Molecular Genetics · 被引 11)
• Proteasomes suppress anticancer drug-induced cytotoxicity by inhibiting mitochondrial protein import and promoting ROS-BNIP3-mediated mitophagy (2025 · Drug Resistance Updates · 被引 4)
• Artesunate attenuates osteoarthritis in mice by promoting MTA1 transcription through a USP7/FoxO1 axis (2024 · Toxicology and Applied Pharmacology · 被引 4)
• Investigation of the Underlying Mechanism of Zhibai Dihuang Pill in Treating Osteoporosis by using Network Pharmacology and Molecular DynamicsSimulation (2022 · Endocrine Metabolic & Immune Disorders - Drug Targets · 被引 3)
• A “one-two punch” strategy to reverse immunosuppressive metabolism and activate T-cell immunity for enhanced cancer checkpoint immunotherapy (2026 · Journal of Nanobiotechnology · 被引 2)
• DUSP22 dephosphorylates LGALS1 to enhance T cell-driven antitumor immunity (2026 · Journal for ImmunoTherapy of Cancer · 被引 1)